(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] CTD PMID:31150632 (+)-Tetrandrine multiple interactions EXP 6480464 tetrandrine inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 mRNA] more ... CTD PMID:17201889 (-)-citrinin multiple interactions ISO RGD:1348351 6480464 [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 mRNA, [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 protein CTD PMID:29673704 (-)-demecolcine increases expression ISO RGD:1348351 6480464 Demecolcine results in increased expression of ACTA2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate affects expression ISO RGD:1616012 6480464 epigallocatechin gallate affects the expression of ACTA2 CTD PMID:25955525 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:19646978 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1616012 6480464 epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA], epigallocatechin gallate inhibits the reaction [Pyruvaldehyde results in increased expression of ACTA2 protein] CTD PMID:20438794 , PMID:22101032 (25R)-cholest-5-ene-3beta,26-diol increases expression ISO RGD:1348351 6480464 27-hydroxycholesterol results in increased expression of ACTA2 protein CTD PMID:33131013 (25R)-cholest-5-ene-3beta,26-diol multiple interactions ISO RGD:1348351 6480464 Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of ACTA2 protein] more ... CTD PMID:33131013 (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid multiple interactions ISO RGD:1616012 6480464 argatroban inhibits the reaction [Dietary Fats results in increased expression of ACTA2 protein] CTD PMID:22841818 (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Mitogens results in increased expression of ACTA2 protein] more ... CTD PMID:21251946 more ... (S)-colchicine multiple interactions EXP 6480464 Colchicine inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 protein], Colchicine inhibits the reaction [Ethanol results in increased expression of ACTA2 protein] CTD PMID:14726149 , PMID:22446813 (S)-naringenin multiple interactions EXP 6480464 naringenin inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 protein] CTD PMID:14709902 (S)-nicotine multiple interactions ISO RGD:1616012 6480464 Nicotine promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA], Nicotine promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:33640489 1,2-dimethylhydrazine multiple interactions ISO RGD:1616012 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ACTA2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1616012 6480464 1, 2-Dimethylhydrazine results in increased expression of ACTA2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ACTA2 mRNA CTD PMID:30723492 1-octadec-9-enoylglycero-3-phosphate increases expression ISO RGD:1616012 6480464 lysophosphatidic acid results in increased expression of ACTA2 mRNA CTD PMID:24706986 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:1616012 6480464 N-(4-chlorophenyl)-1-((3-(furan-2-yl)phenyl)carbonyl)piperidine-3-carboxamide inhibits the reaction [lysophosphatidic acid results in increased expression of ACTA2 mRNA] CTD PMID:24706986 11-deoxycorticosterone multiple interactions ISO RGD:1616012 6480464 Rotenone inhibits the reaction [Desoxycorticosterone results in increased expression of ACTA2 protein] CTD PMID:17596522 11-deoxycorticosterone increases expression ISO RGD:1616012 6480464 Desoxycorticosterone results in increased expression of ACTA2 mRNA, Desoxycorticosterone results in increased expression of ACTA2 protein CTD PMID:17596522 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ACTA2 mRNA CTD PMID:12075121 17alpha-ethynylestradiol multiple interactions ISO RGD:1616012 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ACTA2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1616012 6480464 Ethinyl Estradiol affects the expression of ACTA2 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions EXP 6480464 Estradiol inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:12378635 , PMID:15112349 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 estradiol 3-benzoate promotes the reaction [Thioacetamide results in increased expression of ACTA2 mRNA] CTD PMID:15716488 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1616012 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1616012 6480464 [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACTA2 mRNA more ... CTD PMID:16054899 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACTA2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1616012 6480464 Tetrachlorodibenzodioxin results in increased expression of ACTA2 mRNA CTD PMID:16922920 , PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1348351 6480464 Tetrachlorodibenzodioxin results in increased expression of ACTA2 mRNA, Tetrachlorodibenzodioxin results in increased expression of ACTA2 protein CTD PMID:26860701 , PMID:27697457 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1348351 6480464 AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of ACTA2 protein] more ... CTD PMID:27697457 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1616012 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACTA2 mRNA CTD PMID:15667827 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1616012 6480464 Tetrachlorodibenzodioxin affects the expression of ACTA2 mRNA CTD PMID:20702594 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ACTA2 mRNA CTD PMID:20959002 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1616012 6480464 2 more ... CTD PMID:20702594 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:1348351 6480464 Butylated Hydroxytoluene inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:16757516 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP 6480464 Verapamil inhibits the reaction [[Carbon Tetrachloride co-treated with lard co-treated with Ethanol] results in increased expression of ACTA2 protein] CTD PMID:17223571 2-amino-2-deoxy-D-galactopyranose increases expression EXP 6480464 Galactosamine results in increased expression of ACTA2 mRNA, Galactosamine results in increased expression of ACTA2 protein CTD PMID:27836788 , PMID:27876602 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 Genistein inhibits the reaction [Galactosamine results in increased expression of ACTA2 mRNA] more ... CTD PMID:27836788 , PMID:27876602 2-arachidonoylglycerol multiple interactions EXP 6480464 Acetaldehyde promotes the reaction [glyceryl 2-arachidonate results in increased expression of ACTA2 mRNA] CTD PMID:21863215 2-arachidonoylglycerol increases expression EXP 6480464 glyceryl 2-arachidonate results in increased expression of ACTA2 mRNA CTD PMID:21863215 2-butoxyethanol increases expression ISO RGD:1616012 6480464 n-butoxyethanol results in increased expression of ACTA2 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:1348351 6480464 beta-methylcholine affects the expression of ACTA2 mRNA CTD PMID:21179406 25-hydroxycholesterol increases expression EXP 6480464 25-hydroxycholesterol results in increased expression of ACTA2 mRNA CTD PMID:17161435 25-hydroxycholesterol multiple interactions EXP 6480464 15-deoxyprostaglandin J2 inhibits the reaction [25-hydroxycholesterol results in increased expression of ACTA2 mRNA], alitretinoin promotes the reaction [25-hydroxycholesterol results in increased expression of ACTA2 mRNA] CTD PMID:17161435 26-hydroxycholesterol increases expression ISO RGD:1348351 6480464 27-hydroxycholesterol results in increased expression of ACTA2 protein CTD PMID:33131013 26-hydroxycholesterol multiple interactions ISO RGD:1348351 6480464 Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of ACTA2 protein] more ... CTD PMID:33131013 3,3',4,4'-tetrachlorobiphenyl increases expression ISO RGD:1616012 6480464 3 more ... CTD PMID:30935970 3,4-dihydroxybenzaldehyde multiple interactions EXP 6480464 protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] CTD PMID:25582705 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:1348351 6480464 MK-886 inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] CTD PMID:30677399 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1616012 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTA2 mRNA more ... CTD PMID:16054899 , PMID:27396813 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] more ... CTD PMID:26739621 , PMID:29535048 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1348351 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] more ... CTD PMID:26435214 , PMID:26806094 3-methyladenine multiple interactions ISO RGD:1348351 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] CTD PMID:30677399 3-methylcholanthrene decreases expression ISO RGD:1616012 6480464 Methylcholanthrene results in decreased expression of ACTA2 mRNA CTD PMID:20713471 3-phenylprop-2-enal multiple interactions EXP 6480464 cinnamaldehyde inhibits the reaction [Glucose results in increased expression of ACTA2 protein] CTD PMID:20060012 4,4'-sulfonyldiphenol affects expression ISO RGD:1616012 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of ACTA2 mRNA CTD PMID:30951980 4-Hydroxy-TEMPO multiple interactions EXP 6480464 tempol inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein] CTD PMID:25204689 4-hydroxyhexenal increases expression ISO RGD:1348351 6480464 4-hydroxy-2-hexenal results in increased expression of ACTA2 mRNA CTD PMID:28760545 4-hydroxyphenyl retinamide decreases expression ISO RGD:1616012 6480464 Fenretinide results in decreased expression of ACTA2 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:1616012 6480464 Fenretinide results in increased expression of ACTA2 mRNA CTD PMID:28973697 4-phenylbutyric acid increases expression ISO RGD:1348351 6480464 4-phenylbutyric acid results in increased expression of ACTA2 mRNA CTD PMID:30481203 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Decitabine inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in increased expression of ACTA2 protein] more ... CTD PMID:24211420 , PMID:30010033 5-aza-2'-deoxycytidine affects expression ISO RGD:1348351 6480464 Decitabine affects the expression of ACTA2 mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine decreases expression EXP 6480464 Decitabine results in decreased expression of ACTA2 mRNA CTD PMID:22056649 5-azacytidine multiple interactions ISO RGD:1348351 6480464 Azacitidine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] CTD PMID:22841775 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:31981641 9-cis-retinoic acid multiple interactions EXP 6480464 15-deoxyprostaglandin J2 inhibits the reaction [Alitretinoin results in increased expression of ACTA2 mRNA], Alitretinoin promotes the reaction [25-hydroxycholesterol results in increased expression of ACTA2 mRNA] CTD PMID:17161435 9-cis-retinoic acid increases expression EXP 6480464 Alitretinoin results in increased expression of ACTA2 mRNA CTD PMID:17161435 Ac-Ser-Asp-Lys-Pro-OH multiple interactions ISO RGD:1348351 6480464 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of ACTA2 protein], goralatide inhibits the reaction [AGT protein results in increased expression of ACTA2 protein] CTD PMID:31181250 Ac-Ser-Asp-Lys-Pro-OH multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein], goralatide inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] CTD PMID:31181250 Ac-Ser-Asp-Lys-Pro-OH multiple interactions ISO RGD:1616012 6480464 goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]] more ... CTD PMID:33007385 acetaldehyde multiple interactions EXP 6480464 Acetaldehyde promotes the reaction [glyceryl 2-arachidonate results in increased expression of ACTA2 mRNA] CTD PMID:21863215 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of ACTA2 mRNA CTD PMID:28959563 acteoside decreases expression ISO RGD:1348351 6480464 acteoside results in decreased expression of ACTA2 protein CTD PMID:33522686 aflatoxin B1 increases expression ISO RGD:1348351 6480464 Aflatoxin B1 results in increased expression of ACTA2 mRNA CTD PMID:21632981 , PMID:21641981 aflatoxin B1 decreases methylation ISO RGD:1348351 6480464 Aflatoxin B1 results in decreased methylation of ACTA2 gene CTD PMID:27153756 aflatoxin B1 affects expression ISO RGD:1348351 6480464 Aflatoxin B1 affects the expression of ACTA2 protein CTD PMID:20106945 AICA ribonucleotide multiple interactions ISO RGD:1348351 6480464 AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:27688165 aldehydo-D-glucose multiple interactions ISO RGD:1348351 6480464 4-(4-((5-(4 more ... CTD PMID:21829520 more ... aldehydo-D-glucose increases expression ISO RGD:1348351 6480464 Glucose results in increased expression of ACTA2 mRNA, Glucose results in increased expression of ACTA2 protein CTD PMID:21829520 more ... aldehydo-D-glucose multiple interactions EXP 6480464 cinnamaldehyde inhibits the reaction [Glucose results in increased expression of ACTA2 protein] CTD PMID:20060012 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of ACTA2 protein CTD PMID:20060012 aldosterone increases expression EXP 6480464 Aldosterone results in increased expression of ACTA2 protein CTD PMID:25204689 aldosterone increases expression ISO RGD:1348351 6480464 Aldosterone results in increased expression of ACTA2 mRNA, Aldosterone results in increased expression of ACTA2 protein CTD PMID:17596522 aldosterone multiple interactions ISO RGD:1348351 6480464 eplerenone inhibits the reaction [Aldosterone results in increased expression of ACTA2 mRNA] more ... CTD PMID:17596522 aldosterone multiple interactions EXP 6480464 Spironolactone inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein], tempol inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein] CTD PMID:25204689 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of ACTA2 mRNA, Tretinoin results in increased expression of ACTA2 protein CTD PMID:11675954 more ... all-trans-retinoic acid multiple interactions ISO RGD:1616012 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of ACTA2 mRNA, [bisphenol F co-treated with Tretinoin] results in decreased expression of ACTA2 mRNA CTD PMID:30951980 all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin inhibits the reaction [Doxorubicin results in increased expression of ACTA2 mRNA] CTD PMID:20493835 all-trans-retinoic acid increases expression ISO RGD:1348351 6480464 Tretinoin results in increased expression of ACTA2 mRNA, Tretinoin results in increased expression of ACTA2 protein CTD PMID:17053324 , PMID:17069765 all-trans-retinoic acid multiple interactions ISO RGD:1348351 6480464 [Tretinoin co-treated with Phenylbutyrates co-treated with 1-hydroxy-2-oxo-3 more ... CTD PMID:21274875 , PMID:23284745 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of ACTA2 mRNA CTD PMID:12969142 all-trans-retinol multiple interactions EXP 6480464 Vitamin A inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:16256175 allyl isothiocyanate decreases expression ISO RGD:1616012 6480464 allyl isothiocyanate results in decreased expression of ACTA2 mRNA CTD PMID:24036144 AM-251 multiple interactions ISO RGD:1348351 6480464 AM 251 inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] CTD PMID:27936102 andrographolide decreases expression EXP 6480464 andrographolide results in decreased expression of ACTA2 mRNA, andrographolide results in decreased expression of ACTA2 protein CTD PMID:29355602 andrographolide multiple interactions EXP 6480464 andrographolide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] CTD PMID:31706003 andrographolide multiple interactions ISO RGD:1348351 6480464 andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 mRNA] more ... CTD PMID:29355602 , PMID:31128153 andrographolide decreases expression ISO RGD:1348351 6480464 andrographolide results in decreased expression of ACTA2 mRNA, andrographolide results in decreased expression of ACTA2 protein CTD PMID:29355602 andrographolide multiple interactions ISO RGD:1616012 6480464 andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 mRNA] more ... CTD PMID:29355602 more ... anthocyanin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Paraquat results in increased expression of ACTA2 mRNA], Anthocyanins inhibits the reaction [Paraquat results in increased expression of ACTA2 protein] CTD PMID:30403199 anthocyanin multiple interactions ISO RGD:1616012 6480464 Anthocyanins inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:30056145 anthocyanin decreases expression ISO RGD:1616012 6480464 Anthocyanins results in decreased expression of ACTA2 mRNA, Anthocyanins results in decreased expression of ACTA2 protein CTD PMID:30056145 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1616012 6480464 6 more ... CTD PMID:31447676 apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Mitogens results in increased expression of ACTA2 protein] CTD PMID:29760339 arecoline multiple interactions ISO RGD:1348351 6480464 U 0126 inhibits the reaction [Arecoline results in increased expression of ACTA2 protein] CTD PMID:32441858 arecoline increases expression ISO RGD:1348351 6480464 Arecoline results in increased expression of ACTA2 mRNA, Arecoline results in increased expression of ACTA2 protein CTD PMID:32441858 argatroban multiple interactions ISO RGD:1616012 6480464 argatroban inhibits the reaction [Dietary Fats results in increased expression of ACTA2 protein] CTD PMID:22841818 aristolochic acid multiple interactions ISO RGD:1348351 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of ACTA2 mRNA, GREM1 mutant form inhibits the reaction [aristolochic acid I results in increased expression of ACTA2 protein] CTD PMID:22525892 , PMID:25663515 aristolochic acid increases expression ISO RGD:1616012 6480464 aristolochic acid I results in increased expression of ACTA2 mRNA, aristolochic acid I results in increased expression of ACTA2 protein CTD PMID:31048001 aristolochic acid increases expression ISO RGD:1348351 6480464 aristolochic acid I results in increased expression of ACTA2 mRNA, aristolochic acid I results in increased expression of ACTA2 protein CTD PMID:31048001 Aroclor 1254 decreases expression ISO RGD:1616012 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACTA2 mRNA CTD PMID:23650126 arsane multiple interactions EXP 6480464 Grape Seed Extract inhibits the reaction [Arsenic results in increased expression of ACTA2 mRNA] CTD PMID:24348802 arsane increases expression EXP 6480464 Arsenic results in increased expression of ACTA2 mRNA CTD PMID:24348802 arsenic atom multiple interactions EXP 6480464 Grape Seed Extract inhibits the reaction [Arsenic results in increased expression of ACTA2 mRNA] CTD PMID:24348802 arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of ACTA2 mRNA CTD PMID:24348802 arsenite(3-) multiple interactions ISO RGD:1616012 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of ACTA2 protein CTD PMID:31513886 arsenous acid multiple interactions ISO RGD:1616012 6480464 [Arsenic Trioxide co-treated with Bleomycin] results in decreased expression of ACTA2 mRNA, Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] CTD PMID:24762191 , PMID:30677399 arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of ACTA2 mRNA] more ... CTD PMID:31612257 arsenous acid decreases expression ISO RGD:1348351 6480464 Arsenic Trioxide results in decreased expression of ACTA2 mRNA, Arsenic Trioxide results in decreased expression of ACTA2 protein CTD PMID:30317545 arsenous acid multiple interactions ISO RGD:1348351 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] more ... CTD PMID:24762191 more ... arsenous acid increases expression ISO RGD:1616012 6480464 Arsenic Trioxide results in increased expression of ACTA2 protein CTD PMID:30677399 arsenous acid increases expression ISO RGD:1348351 6480464 Arsenic Trioxide results in increased expression of ACTA2 mRNA, Arsenic Trioxide results in increased expression of ACTA2 protein CTD PMID:30677399 , PMID:32240679 artesunate decreases expression ISO RGD:1348351 6480464 Artesunate results in decreased expression of ACTA2 mRNA, Artesunate results in decreased expression of ACTA2 protein CTD PMID:30551460 artesunate multiple interactions ISO RGD:1616012 6480464 Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:30551460 artesunate multiple interactions ISO RGD:1348351 6480464 Deferoxamine inhibits the reaction [Artesunate results in decreased expression of ACTA2 mRNA] CTD PMID:30551460 ATP multiple interactions ISO RGD:1348351 6480464 3-(5-(2 more ... CTD PMID:32721574 atrazine increases expression ISO RGD:1348351 6480464 Atrazine results in increased expression of ACTA2 mRNA CTD PMID:22378314 baicalein decreases expression ISO RGD:1348351 6480464 baicalein results in decreased expression of ACTA2 protein CTD PMID:30201452 baicalein multiple interactions ISO RGD:1348351 6480464 baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] more ... CTD PMID:30201452 benazepril multiple interactions EXP 6480464 [irbesartan co-treated with benazepril] results in decreased expression of ACTA2 protein, benazepril inhibits the reaction [Doxorubicin results in increased expression of ACTA2 mRNA] CTD PMID:15149348 , PMID:20493835 benzene decreases expression ISO RGD:1348351 6480464 Benzene results in decreased expression of ACTA2 mRNA CTD PMID:20036648 benzo[a]pyrene decreases expression ISO RGD:1616012 6480464 Benzo(a)pyrene results in decreased expression of ACTA2 mRNA CTD PMID:22610609 benzo[a]pyrene affects methylation ISO RGD:1348351 6480464 Benzo(a)pyrene affects the methylation of ACTA2 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1348351 6480464 Benzo(a)pyrene results in increased expression of ACTA2 mRNA CTD PMID:20064835 more ... benzo[a]pyrene increases expression ISO RGD:1616012 6480464 Benzo(a)pyrene results in increased expression of ACTA2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1348351 6480464 Benzo(a)pyrene results in decreased expression of ACTA2 mRNA CTD PMID:22581694 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1348351 6480464 7 more ... CTD PMID:26238291 berberine decreases expression EXP 6480464 Berberine results in decreased expression of ACTA2 protein CTD PMID:17973934 beryllium sulfate increases expression ISO RGD:1348351 6480464 beryllium sulfate results in increased expression of ACTA2 mRNA CTD PMID:16314022 betulin multiple interactions EXP 6480464 betulin inhibits the reaction [Ethanol results in increased expression of ACTA2 protein] CTD PMID:21172400 betulinic acid multiple interactions EXP 6480464 betulinic acid inhibits the reaction [Ethanol results in increased expression of ACTA2 protein], betulinic acid inhibits the reaction [Thioacetamide results in increased expression of ACTA2] CTD PMID:21172400 , PMID:22285267 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of ACTA2 mRNA CTD PMID:16648578 bezafibrate multiple interactions EXP 6480464 Bezafibrate inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] CTD PMID:18513333 bezafibrate multiple interactions ISO RGD:1616012 6480464 Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACTA2 mRNA] CTD PMID:18513333 bezafibrate decreases expression EXP 6480464 Bezafibrate results in decreased expression of ACTA2 protein CTD PMID:12657956 bis(2-chloroethyl) sulfide increases expression ISO RGD:1348351 6480464 Mustard Gas results in increased expression of ACTA2 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1348351 6480464 Diethylhexyl Phthalate results in increased expression of ACTA2 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ACTA2 mRNA CTD PMID:12075121 bisphenol A increases expression ISO RGD:1616012 6480464 bisphenol A results in increased expression of ACTA2 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1616012 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of ACTA2 mRNA CTD PMID:30951980 bisphenol A affects expression ISO RGD:1348351 6480464 bisphenol A affects the expression of ACTA2 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1348351 6480464 bisphenol A results in decreased expression of ACTA2 mRNA CTD PMID:27685785 , PMID:29275510 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Dietary Fats] results in increased expression of ACTA2 mRNA, [bisphenol A co-treated with Dietary Fats] results in increased expression of ACTA2 protein CTD PMID:25112833 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ACTA2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1616012 6480464 bisphenol A results in decreased expression of ACTA2 mRNA, bisphenol A results in decreased expression of ACTA2 protein CTD PMID:25862758 , PMID:26063408 bisphenol F increases expression ISO RGD:1616012 6480464 bisphenol F results in increased expression of ACTA2 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:1616012 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ACTA2 mRNA CTD PMID:30951980 bleomycin A2 increases expression ISO RGD:1616012 6480464 Bleomycin results in increased expression of ACTA2 mRNA, Bleomycin results in increased expression of ACTA2 protein CTD PMID:14609568 more ... bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of ACTA2 protein CTD PMID:21381050 more ... bleomycin A2 multiple interactions ISO RGD:1616012 6480464 (3R)-((2 more ... CTD PMID:14609568 more ... bleomycin A2 multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] more ... CTD PMID:21381050 more ... boric acid decreases expression ISO RGD:1348351 6480464 boric acid results in decreased expression of ACTA2 protein CTD PMID:25637568 buta-1,3-diene decreases expression ISO RGD:1616012 6480464 1, 3-butadiene results in decreased expression of ACTA2 mRNA CTD PMID:29038090 C.I. Natural Red 20 decreases expression ISO RGD:1348351 6480464 shikonin results in decreased expression of ACTA2 mRNA CTD PMID:25591861 cadmium dichloride increases expression ISO RGD:1616012 6480464 Cadmium Chloride results in increased expression of ACTA2 protein CTD PMID:28341147 cadmium dichloride increases expression ISO RGD:1348351 6480464 Cadmium Chloride results in increased expression of ACTA2 protein CTD PMID:28341147 caffeine increases expression EXP 6480464 Caffeine results in increased expression of ACTA2 mRNA CTD PMID:29055810 calcitriol increases expression ISO RGD:1348351 6480464 Calcitriol results in increased expression of ACTA2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1616012 6480464 Calcitriol inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] CTD PMID:26520185 calcitriol multiple interactions ISO RGD:1348351 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ACTA2 mRNA CTD PMID:21592394 captan decreases expression ISO RGD:1616012 6480464 Captan results in decreased expression of ACTA2 mRNA CTD PMID:31558096 captopril multiple interactions ISO RGD:1616012 6480464 Captopril inhibits the reaction [AGT protein results in increased expression of ACTA2 protein], Captopril inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] CTD PMID:33007385 captopril multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein], Captopril inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] CTD PMID:31181250 captopril multiple interactions ISO RGD:1348351 6480464 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of ACTA2 protein], Captopril inhibits the reaction [AGT protein results in increased expression of ACTA2 protein] CTD PMID:31181250 carbon nanotube increases expression ISO RGD:1348351 6480464 Nanotubes more ... CTD PMID:22081859 , PMID:24389112 carbon nanotube increases expression ISO RGD:1616012 6480464 Nanotubes more ... CTD PMID:25554681 carvedilol decreases expression EXP 6480464 carvedilol results in decreased expression of ACTA2 protein CTD PMID:20403466 carvedilol multiple interactions EXP 6480464 Carvedilol inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] more ... CTD PMID:22413959 , PMID:30254303 celastrol multiple interactions ISO RGD:1616012 6480464 celastrol inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] more ... CTD PMID:29789558 , PMID:31901889 celastrol multiple interactions ISO RGD:1348351 6480464 celastrol inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:29789558 celecoxib decreases expression EXP 6480464 Celecoxib results in decreased expression of ACTA2 mRNA, Celecoxib results in decreased expression of ACTA2 protein CTD PMID:19201774 celecoxib multiple interactions EXP 6480464 Celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:16420518 ceruletide increases expression ISO RGD:1616012 6480464 Ceruletide results in increased expression of ACTA2 protein CTD PMID:25035110 ceruletide multiple interactions ISO RGD:1616012 6480464 PTHLH protein promotes the reaction [Ceruletide results in increased expression of ACTA2 protein] CTD PMID:25035110 chenodeoxycholic acid multiple interactions ISO RGD:1616012 6480464 Chenodeoxycholic Acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 mRNA] CTD PMID:27773935 chlordecone multiple interactions ISO RGD:1616012 6480464 Chlordecone promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:26853152 chlorogenic acid multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA], Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:23146752 chlorohydrocarbon multiple interactions ISO RGD:1616012 6480464 [Hydrocarbons more ... CTD PMID:31313498 chlorothalonil increases expression ISO RGD:1348351 6480464 tetrachloroisophthalonitrile metabolite results in increased expression of ACTA2 mRNA CTD PMID:32289622 chlorpyrifos increases expression ISO RGD:1616012 6480464 Chlorpyrifos results in increased expression of ACTA2 protein CTD PMID:32715474 choline multiple interactions ISO RGD:1616012 6480464 [Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACTA2 mRNA more ... CTD PMID:18513333 more ... choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 protein, geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 mRNA] CTD PMID:26695085 chromium(6+) multiple interactions ISO RGD:1616012 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ACTA2 protein, SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ACTA2 protein] CTD PMID:31756458 chrysin multiple interactions ISO RGD:1616012 6480464 chrysin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] CTD PMID:26297989 ciglitazone multiple interactions ISO RGD:1348351 6480464 ciglitazone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] CTD PMID:18162602 cisplatin affects expression ISO RGD:1348351 6480464 Cisplatin affects the expression of ACTA2 mRNA CTD PMID:23300844 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ACTA2 mRNA, Cisplatin results in increased expression of ACTA2 protein CTD PMID:31612257 cisplatin multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of ACTA2 mRNA] more ... CTD PMID:31612257 cisplatin increases expression ISO RGD:1348351 6480464 Cisplatin results in increased expression of ACTA2 mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:1616012 6480464 Clobetasol results in increased expression of ACTA2 mRNA CTD PMID:27462272 clodronic acid multiple interactions EXP 6480464 [Clodronic Acid co-treated with Thioacetamide] results in increased expression of ACTA2 protein CTD PMID:26957569 Clofop multiple interactions EXP 6480464 fenofibric acid inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] CTD PMID:18513333 cobalt dichloride multiple interactions ISO RGD:1348351 6480464 [cobaltous chloride co-treated with Cyclosporine] results in decreased expression of ACTA2 protein CTD PMID:22343435 colforsin daropate hydrochloride multiple interactions EXP 6480464 Colforsin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:27590029 colforsin daropate hydrochloride decreases expression ISO RGD:1348351 6480464 Colforsin results in decreased expression of ACTA2 protein CTD PMID:21603974 copper atom multiple interactions ISO RGD:1616012 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ACTA2 mRNA CTD PMID:15467011 copper atom multiple interactions ISO RGD:1348351 6480464 [Disulfiram binds to Copper] which results in increased expression of ACTA2 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:1616012 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ACTA2 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1348351 6480464 [Disulfiram binds to Copper] which results in increased expression of ACTA2 mRNA CTD PMID:24690739 copper(II) sulfate decreases expression ISO RGD:1348351 6480464 Copper Sulfate results in decreased expression of ACTA2 mRNA CTD PMID:19549813 copper(II) sulfate increases expression ISO RGD:1616012 6480464 Copper Sulfate results in increased expression of ACTA2 mRNA, Copper Sulfate results in increased expression of ACTA2 protein CTD PMID:33744278 crocidolite asbestos increases expression ISO RGD:1348351 6480464 Asbestos more ... CTD PMID:22573546 , PMID:24160326 crocidolite asbestos increases expression ISO RGD:1616012 6480464 Asbestos, Crocidolite results in increased expression of ACTA2 protein CTD PMID:28056339 cucurbitacin B multiple interactions ISO RGD:1616012 6480464 cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] CTD PMID:29250925 cucurbitacin E decreases expression EXP 6480464 cucurbitacin E results in decreased expression of ACTA2 mRNA, cucurbitacin E results in decreased expression of ACTA2 protein CTD PMID:27363783 cucurbitacin E multiple interactions ISO RGD:1616012 6480464 cucurbitacin E inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:27363783 curcumin multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of ACTA2 mRNA] more ... CTD PMID:17355460 more ... curcumin multiple interactions ISO RGD:1616012 6480464 Curcumin inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:27363783 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of ACTA2 mRNA, Curcumin results in decreased expression of ACTA2 protein CTD PMID:17531121 cyanocob(III)alamin multiple interactions ISO RGD:1616012 6480464 Vitamin B 12 inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 mRNA] CTD PMID:18239293 cyclosporin A increases expression ISO RGD:1616012 6480464 Cyclosporine results in increased expression of ACTA2 protein CTD PMID:21354196 cyclosporin A decreases expression ISO RGD:1348351 6480464 Cyclosporine results in decreased expression of ACTA2 mRNA CTD PMID:27989131 cyclosporin A multiple interactions ISO RGD:1348351 6480464 [cobaltous chloride co-treated with Cyclosporine] results in decreased expression of ACTA2 protein CTD PMID:22343435 cystamine multiple interactions EXP 6480464 Cystamine inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA], Cystamine inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:17708605 cytochalasin D multiple interactions ISO RGD:1348351 6480464 Cytochalasin D inhibits the reaction [Oxygen results in increased expression of ACTA2 mRNA], Cytochalasin D inhibits the reaction [Oxygen results in increased expression of ACTA2 protein] CTD PMID:23517783 cytochalasin D increases expression EXP 6480464 Cytochalasin D results in increased expression of ACTA2 mRNA CTD PMID:11035001 D-glucose multiple interactions EXP 6480464 cinnamaldehyde inhibits the reaction [Glucose results in increased expression of ACTA2 protein] CTD PMID:20060012 D-glucose increases expression ISO RGD:1348351 6480464 Glucose results in increased expression of ACTA2 mRNA, Glucose results in increased expression of ACTA2 protein CTD PMID:21829520 more ... D-glucose multiple interactions ISO RGD:1348351 6480464 4-(4-((5-(4 more ... CTD PMID:21829520 more ... D-glucose increases expression EXP 6480464 Glucose results in increased expression of ACTA2 protein CTD PMID:20060012 dapagliflozin multiple interactions EXP 6480464 dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of ACTA2 protein], Metformin promotes the reaction [dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of ACTA2 protein]] CTD PMID:30551545 DAPT multiple interactions ISO RGD:1348351 6480464 1 more ... CTD PMID:31348943 DDT increases expression EXP 6480464 DDT results in increased expression of ACTA2 mRNA CTD PMID:30207508 delphinidin multiple interactions ISO RGD:1616012 6480464 delphinidin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:20371262 desferrioxamine B decreases expression EXP 6480464 Deferoxamine results in decreased expression of ACTA2 protein CTD PMID:18032466 desferrioxamine B increases expression ISO RGD:1348351 6480464 Deferoxamine results in increased expression of ACTA2 mRNA CTD PMID:30551460 desferrioxamine B multiple interactions ISO RGD:1348351 6480464 Deferoxamine inhibits the reaction [Artesunate results in decreased expression of ACTA2 mRNA] CTD PMID:30551460 dexamethasone multiple interactions ISO RGD:1616012 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTA2 mRNA more ... CTD PMID:16054899 more ... dexamethasone multiple interactions ISO RGD:1348351 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] more ... CTD PMID:26435214 , PMID:26806094 dexamethasone multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] more ... CTD PMID:26739621 , PMID:29535048 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of ACTA2 mRNA CTD PMID:14618091 diacetylmonoxime affects localization ISO RGD:1348351 6480464 diacetylmonoxime affects the localization of ACTA2 protein CTD PMID:11591817 diacetylmonoxime decreases expression EXP 6480464 diacetylmonoxime results in decreased expression of ACTA2 CTD PMID:11868461 Diallyl sulfide multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] CTD PMID:23656969 diallyl trisulfide multiple interactions ISO RGD:1348351 6480464 diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of ACTA2 protein], diallyl trisulfide inhibits the reaction [propargylglycine results in decreased expression of ACTA2 protein] CTD PMID:28157488 diarsenic trioxide increases expression ISO RGD:1616012 6480464 Arsenic Trioxide results in increased expression of ACTA2 protein CTD PMID:30677399 diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of ACTA2 mRNA] more ... CTD PMID:31612257 diarsenic trioxide increases expression ISO RGD:1348351 6480464 Arsenic Trioxide results in increased expression of ACTA2 mRNA, Arsenic Trioxide results in increased expression of ACTA2 protein CTD PMID:30677399 , PMID:32240679 diarsenic trioxide multiple interactions ISO RGD:1616012 6480464 [Arsenic Trioxide co-treated with Bleomycin] results in decreased expression of ACTA2 mRNA, Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] CTD PMID:24762191 , PMID:30677399 diarsenic trioxide decreases expression ISO RGD:1348351 6480464 Arsenic Trioxide results in decreased expression of ACTA2 mRNA, Arsenic Trioxide results in decreased expression of ACTA2 protein CTD PMID:30317545 diarsenic trioxide multiple interactions ISO RGD:1348351 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] more ... CTD PMID:24762191 more ... dibenziodolium decreases expression ISO RGD:1348351 6480464 diphenyleneiodonium results in decreased expression of ACTA2 protein CTD PMID:30502394 dibenziodolium multiple interactions ISO RGD:1348351 6480464 diphenyleneiodonium promotes the reaction [gamma-mangostin results in decreased expression of ACTA2 protein], gamma-mangostin promotes the reaction [diphenyleneiodonium results in decreased expression of ACTA2 protein] CTD PMID:30502394 dibutyl phthalate increases expression ISO RGD:1616012 6480464 Dibutyl Phthalate results in increased expression of ACTA2 mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of ACTA2 mRNA] more ... CTD PMID:32860865 dibutyl phthalate affects expression EXP 6480464 Dibutyl Phthalate affects the expression of ACTA2 mRNA, Dibutyl Phthalate affects the expression of ACTA2 protein CTD PMID:32860865 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ACTA2 mRNA, Dibutyl Phthalate results in increased expression of ACTA2 protein CTD PMID:28919491 , PMID:32860865 dicrotophos increases expression ISO RGD:1348351 6480464 dicrotophos results in increased expression of ACTA2 mRNA CTD PMID:28302478 diethyl malate affects expression ISO RGD:1616012 6480464 diethyl malate affects the expression of ACTA2 mRNA CTD PMID:24814887 dihydrolipoic acid multiple interactions EXP 6480464 dihydrolipoic acid inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:21251946 diisononyl phthalate multiple interactions ISO RGD:1616012 6480464 [OVAL protein results in increased susceptibility to diisononyl phthalate] which results in increased expression of ACTA2 protein more ... CTD PMID:29758289 dimethyl fumarate multiple interactions EXP 6480464 Dimethyl Fumarate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:30703375 dimethyl sulfoxide multiple interactions EXP 6480464 Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:11682029 diminazene diaceturate decreases expression ISO RGD:1348351 6480464 diminazene aceturate results in decreased expression of ACTA2 protein CTD PMID:29977014 Diosbulbin B increases expression ISO RGD:1616012 6480464 diosbulbin B results in increased expression of ACTA2 mRNA, diosbulbin B results in increased expression of ACTA2 protein CTD PMID:30401638 dioxygen affects expression ISO RGD:1616012 6480464 Oxygen deficiency affects the expression of ACTA2 protein CTD PMID:20164382 dioxygen multiple interactions ISO RGD:1348351 6480464 [Oxygen deficiency co-treated with Oxygen] results in decreased expression of ACTA2 protein more ... CTD PMID:23517783 , PMID:28157488 dioxygen increases expression ISO RGD:1348351 6480464 Oxygen results in increased expression of ACTA2 mRNA, Oxygen results in increased expression of ACTA2 protein CTD PMID:23517783 dioxygen increases expression ISO RGD:1616012 6480464 Oxygen results in increased expression of ACTA2 mRNA, Oxygen results in increased expression of ACTA2 protein CTD PMID:22363622 , PMID:23517783 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of ACTA2 mRNA, Oxygen results in increased expression of ACTA2 protein CTD PMID:16617452 dioxygen multiple interactions ISO RGD:1616012 6480464 1 more ... CTD PMID:22363622 , PMID:23517783 dioxygen multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of ACTA2 mRNA]] more ... CTD PMID:16617452 disodium selenite multiple interactions ISO RGD:1348351 6480464 dimethyl mercaptosuccinate inhibits the reaction [Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]], Sodium Selenite inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:16757516 disulfiram multiple interactions ISO RGD:1348351 6480464 [Disulfiram binds to Copper] which results in increased expression of ACTA2 mRNA CTD PMID:24690739 diuron increases expression EXP 6480464 Diuron results in increased expression of ACTA2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1348351 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1616012 6480464 Doxorubicin results in increased expression of ACTA2 protein CTD PMID:21920376 , PMID:28318631 doxorubicin decreases expression ISO RGD:1348351 6480464 Doxorubicin results in decreased expression of ACTA2 mRNA CTD PMID:29803840 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ACTA2 mRNA, Doxorubicin results in increased expression of ACTA2 protein CTD PMID:19225054 more ... doxorubicin multiple interactions EXP 6480464 benazepril inhibits the reaction [Doxorubicin results in increased expression of ACTA2 mRNA] more ... CTD PMID:20493835 , PMID:33484087 doxorubicin multiple interactions ISO RGD:1616012 6480464 CDKN1A gene mutant form inhibits the reaction [Doxorubicin results in increased expression of ACTA2 protein], Niclosamide inhibits the reaction [Doxorubicin results in increased expression of ACTA2 protein] CTD PMID:21920376 , PMID:28318631 doxycycline multiple interactions ISO RGD:1616012 6480464 Doxycycline inhibits the reaction [Isoproterenol results in decreased expression of ACTA2 mRNA] CTD PMID:18089841 ebselen multiple interactions ISO RGD:1348351 6480464 ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:16757516 emodin decreases expression EXP 6480464 Emodin results in decreased expression of ACTA2 protein CTD PMID:15288473 , PMID:27989784 emodin multiple interactions EXP 6480464 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]] more ... CTD PMID:15288473 , PMID:27989784 enalapril decreases expression EXP 6480464 Enalapril results in decreased expression of ACTA2 protein CTD PMID:19349682 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ACTA2 protein CTD PMID:22198180 entinostat multiple interactions ISO RGD:1348351 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTA2 mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:1348351 6480464 entinostat results in decreased expression of ACTA2 mRNA CTD PMID:26272509 eplerenone multiple interactions ISO RGD:1348351 6480464 eplerenone inhibits the reaction [Aldosterone results in increased expression of ACTA2 mRNA], eplerenone inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein] CTD PMID:17596522 ergosta-4,6,8(14),22-tetraen-3-one multiple interactions ISO RGD:1348351 6480464 ergosta-4 more ... CTD PMID:28578904 ethanol multiple interactions EXP 6480464 8-(4-methoxyphenyl)-4-oxo-4 more ... CTD PMID:16622519 more ... ethanol increases expression ISO RGD:1616012 6480464 Ethanol results in increased expression of ACTA2 mRNA, Ethanol results in increased expression of ACTA2 protein CTD PMID:27688165 more ... ethanol multiple interactions ISO RGD:1616012 6480464 [Ethanol co-treated with Carbon Tetrachloride co-treated with 4-O-methylhonokiol] results in increased expression of ACTA2 mRNA more ... CTD PMID:21863215 more ... ethanol increases expression EXP 6480464 Ethanol results in increased expression of ACTA2 mRNA, Ethanol results in increased expression of ACTA2 protein CTD PMID:21172400 more ... ethyl methanesulfonate increases expression ISO RGD:1348351 6480464 Ethyl Methanesulfonate results in increased expression of ACTA2 mRNA CTD PMID:23649840 fasudil decreases expression ISO RGD:1616012 6480464 fasudil results in decreased expression of ACTA2 mRNA CTD PMID:22465603 fenamidone multiple interactions ISO RGD:1616012 6480464 sulforaphane inhibits the reaction [fenamidone results in increased expression of ACTA2 mRNA] CTD PMID:27029645 fenamidone increases expression ISO RGD:1616012 6480464 fenamidone results in increased expression of ACTA2 mRNA CTD PMID:27029645 fenofibrate multiple interactions ISO RGD:1348351 6480464 Fenofibrate inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] CTD PMID:32613381 fenofibrate multiple interactions ISO RGD:1616012 6480464 Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein] CTD PMID:28871336 ferulic acid multiple interactions ISO RGD:1616012 6480464 ferulic acid inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] CTD PMID:33428986 finasteride multiple interactions EXP 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of ACTA2 mRNA] CTD PMID:27866977 fingolimod hydrochloride multiple interactions ISO RGD:1616012 6480464 Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of ACTA2 mRNA], Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of ACTA2 protein] CTD PMID:24893116 folic acid multiple interactions ISO RGD:1616012 6480464 6 more ... CTD PMID:20938992 more ... folic acid affects expression ISO RGD:1348351 6480464 Folic Acid affects the expression of ACTA2 mRNA CTD PMID:17320366 folic acid increases expression ISO RGD:1616012 6480464 Folic Acid deficiency results in increased expression of ACTA2 protein, Folic Acid results in increased expression of ACTA2 protein CTD PMID:21647593 more ... folpet decreases expression ISO RGD:1616012 6480464 folpet results in decreased expression of ACTA2 mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:1348351 6480464 Formaldehyde results in increased expression of ACTA2 mRNA CTD PMID:23649840 formaldehyde multiple interactions ISO RGD:1616012 6480464 [OVAL protein results in increased susceptibility to Formaldehyde] which results in increased expression of ACTA2 protein more ... CTD PMID:29758289 formoterol fumarate multiple interactions ISO RGD:1348351 6480464 ICI 118551 inhibits the reaction [Formoterol Fumarate results in decreased expression of ACTA2 protein] CTD PMID:21603974 formoterol fumarate decreases expression ISO RGD:1348351 6480464 Formoterol Fumarate results in decreased expression of ACTA2 mRNA, Formoterol Fumarate results in decreased expression of ACTA2 protein CTD PMID:21603974 fructose increases expression EXP 6480464 Fructose results in increased expression of ACTA2 protein CTD PMID:21704028 fructose multiple interactions EXP 6480464 [Streptozocin co-treated with Fructose] results in increased expression of ACTA2 protein more ... CTD PMID:21704028 , PMID:30551545 gadolinium trichloride multiple interactions EXP 6480464 gadolinium chloride inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:11408273 gamma-mangostin multiple interactions ISO RGD:1348351 6480464 [gamma-mangostin co-treated with MK 2206] results in decreased expression of ACTA2 protein more ... CTD PMID:30502394 gamma-mangostin multiple interactions ISO RGD:1616012 6480464 gamma-mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:30502394 gamma-mangostin decreases expression ISO RGD:1348351 6480464 gamma-mangostin results in decreased expression of ACTA2 protein CTD PMID:30502394 Ganoderic acid A multiple interactions ISO RGD:1616012 6480464 ganoderic acid A inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:34029542 gefitinib multiple interactions ISO RGD:1616012 6480464 [Gefitinib co-treated with CCL2 protein] results in increased expression of ACTA2 protein, [Gefitinib results in increased secretion of CCL2 protein] which results in increased expression of ACTA2 protein CTD PMID:33248157 gefitinib decreases expression ISO RGD:1616012 6480464 Gefitinib results in decreased expression of ACTA2 protein CTD PMID:33248157 genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [Fructose results in increased expression of ACTA2 protein] more ... CTD PMID:21704028 , PMID:27876602 genistein decreases expression ISO RGD:1348351 6480464 Genistein results in decreased expression of ACTA2 mRNA CTD PMID:20884965 , PMID:22228119 genistein increases expression EXP 6480464 Genistein results in increased expression of ACTA2 mRNA CTD PMID:12075121 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 mRNA] CTD PMID:26695085 Ginkgoic acid multiple interactions ISO RGD:1616012 6480464 ginkgolic acid inhibits the reaction [AGT protein modified form results in increased expression of ACTA2 protein] CTD PMID:29524504 Ginkgolide A multiple interactions ISO RGD:1616012 6480464 ginkgolide A inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:31697926 glucagon multiple interactions ISO RGD:1616012 6480464 Glucagon analog inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of ACTA2 mRNA], Glucagon analog inhibits the reaction [LEPR gene mutant form results in increased expression of ACTA2 mRNA] CTD PMID:29988851 glucose increases expression EXP 6480464 Glucose results in increased expression of ACTA2 protein CTD PMID:20060012 glucose increases expression ISO RGD:1348351 6480464 Glucose results in increased expression of ACTA2 mRNA, Glucose results in increased expression of ACTA2 protein CTD PMID:21829520 more ... glucose multiple interactions EXP 6480464 cinnamaldehyde inhibits the reaction [Glucose results in increased expression of ACTA2 protein] CTD PMID:20060012 glucose multiple interactions ISO RGD:1348351 6480464 4-(4-((5-(4 more ... CTD PMID:21829520 more ... glycyrrhetinate multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Monocrotaline results in increased expression of ACTA2 protein] CTD PMID:31325423 glycyrrhetinic acid multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Monocrotaline results in increased expression of ACTA2 protein] CTD PMID:31325423 glycyrrhizinic acid decreases expression ISO RGD:1348351 6480464 Glycyrrhizic Acid results in decreased expression of ACTA2 protein CTD PMID:33522686 graphene oxide decreases expression ISO RGD:1616012 6480464 graphene oxide analog results in decreased expression of ACTA2 mRNA CTD PMID:33227293 heparin multiple interactions EXP 6480464 Heparin analog inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:16904936 heptachlor increases expression ISO RGD:1348351 6480464 Heptachlor results in increased expression of ACTA2 mRNA, Heptachlor results in increased expression of ACTA2 protein CTD PMID:30719927 hesperetin multiple interactions EXP 6480464 [hesperetin analog co-treated with bisperoxovanadium analog] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] more ... CTD PMID:27818223 hexachlorobenzene increases expression ISO RGD:1616012 6480464 Hexachlorobenzene results in increased expression of ACTA2 protein CTD PMID:28923513 hexadecanoic acid multiple interactions ISO RGD:1348351 6480464 [Oleic Acid co-treated with Palmitic Acid] results in increased expression of ACTA2 mRNA CTD PMID:26187275 homocysteine multiple interactions ISO RGD:1616012 6480464 [Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 mRNA more ... CTD PMID:21647593 homocysteine increases expression ISO RGD:1616012 6480464 Homocysteine results in increased expression of ACTA2 mRNA, Homocysteine results in increased expression of ACTA2 protein CTD PMID:21647593 Honokiol multiple interactions ISO RGD:1348351 6480464 honokiol inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:32032644 Honokiol affects expression EXP 6480464 honokiol affects the expression of ACTA2 protein CTD PMID:21265825 Honokiol multiple interactions EXP 6480464 honokiol inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:21265825 Honokiol multiple interactions ISO RGD:1616012 6480464 honokiol inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] CTD PMID:32032644 hyaluronic acid multiple interactions ISO RGD:1348351 6480464 [CD44 protein affects the abundance of Hyaluronic Acid] affects the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:31285260 hydrogen peroxide multiple interactions EXP 6480464 Progesterone promotes the reaction [Hydrogen Peroxide results in increased expression of ACTA2 protein], tetramethylpyrazine inhibits the reaction [Hydrogen Peroxide results in increased expression of ACTA2 mRNA] CTD PMID:16284289 , PMID:23022513 hydrogen peroxide increases expression ISO RGD:1616012 6480464 Hydrogen Peroxide results in increased expression of ACTA2 protein CTD PMID:32659284 hydrogen peroxide multiple interactions ISO RGD:1616012 6480464 2-(5-benzo(1 more ... CTD PMID:32659284 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of ACTA2 mRNA, Hydrogen Peroxide results in increased expression of ACTA2 protein CTD PMID:16284289 , PMID:23022513 ICI 118551 multiple interactions ISO RGD:1348351 6480464 ICI 118551 inhibits the reaction [Formoterol Fumarate results in decreased expression of ACTA2 protein] CTD PMID:21603974 imperatorin multiple interactions EXP 6480464 imperatorin analog inhibits the reaction [AGT protein results in decreased expression of ACTA2 protein] CTD PMID:25727310 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of ACTA2 mRNA CTD PMID:21396975 irbesartan multiple interactions EXP 6480464 [irbesartan co-treated with benazepril] results in decreased expression of ACTA2 protein CTD PMID:15149348 irinotecan increases expression ISO RGD:1616012 6480464 Irinotecan results in increased expression of ACTA2 protein CTD PMID:28454924 irinotecan multiple interactions ISO RGD:1616012 6480464 Silymarin affects the reaction [Irinotecan results in increased expression of ACTA2 protein] CTD PMID:28454924 iron(2+) sulfate (anhydrous) multiple interactions EXP 6480464 [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of ACTA2 protein CTD PMID:7593635 isoorientin multiple interactions EXP 6480464 homoorientin inhibits the reaction [Ethanol results in increased expression of ACTA2 protein] CTD PMID:22446813 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of ACTA2 mRNA, Isoproterenol results in increased expression of ACTA2 protein CTD PMID:24945829 , PMID:28526319 isoprenaline decreases expression ISO RGD:1616012 6480464 Isoproterenol results in decreased expression of ACTA2 mRNA CTD PMID:18089841 , PMID:20003209 isoprenaline multiple interactions ISO RGD:1616012 6480464 Doxycycline inhibits the reaction [Isoproterenol results in decreased expression of ACTA2 mRNA] CTD PMID:18089841 isorhamnetin multiple interactions ISO RGD:1348351 6480464 3-methylquercetin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA], 3-methylquercetin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:27151496 isorhamnetin multiple interactions ISO RGD:1616012 6480464 3-methylquercetin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] more ... CTD PMID:27151496 ivermectin decreases expression ISO RGD:1348351 6480464 Ivermectin results in decreased expression of ACTA2 protein CTD PMID:32959892 jaspamide increases expression ISO RGD:1348351 6480464 jasplakinolide results in increased expression of ACTA2 protein CTD PMID:23517783 jaspamide increases expression EXP 6480464 jasplakinolide results in increased expression of ACTA2 mRNA CTD PMID:11035001 kaempferol decreases expression ISO RGD:1616012 6480464 kaempferol results in decreased expression of ACTA2 protein CTD PMID:26683311 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of ACTA2 protein CTD PMID:7593635 L-ascorbic acid multiple interactions ISO RGD:1348351 6480464 [Ascorbic Acid co-treated with TGFB1 protein] results in increased expression of ACTA2 mRNA more ... CTD PMID:17053324 more ... L-cysteine multiple interactions EXP 6480464 Cysteine inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:15158331 L-cysteine decreases expression EXP 6480464 Cysteine results in decreased expression of ACTA2 protein CTD PMID:15158331 L-methionine multiple interactions ISO RGD:1616012 6480464 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACTA2 mRNA more ... CTD PMID:18513333 more ... L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 protein more ... CTD PMID:15158331 , PMID:26695085 L-methionine decreases expression EXP 6480464 Methionine results in decreased expression of ACTA2 protein CTD PMID:15158331 lamivudine decreases expression ISO RGD:1348351 6480464 Lamivudine results in decreased expression of ACTA2 protein CTD PMID:11738102 lapatinib multiple interactions ISO RGD:1348351 6480464 [lapatinib results in decreased susceptibility to lapatinib] which results in increased expression of ACTA2 protein, Niclosamide inhibits the reaction [[lapatinib results in decreased susceptibility to lapatinib] which results in increased expression of ACTA2 protein] CTD PMID:26643609 latrunculin B decreases expression EXP 6480464 latrunculin B results in decreased expression of ACTA2 mRNA CTD PMID:11035001 latrunculin B multiple interactions EXP 6480464 latrunculin B inhibits the reaction [RHOA protein results in increased expression of ACTA2 mRNA] CTD PMID:11035001 leukotriene B4 increases expression ISO RGD:1348351 6480464 Leukotriene B4 results in increased expression of ACTA2 protein CTD PMID:27697457 leukotriene B4 increases expression ISO RGD:1616012 6480464 Leukotriene B4 results in increased expression of ACTA2 mRNA CTD PMID:30818366 limonene multiple interactions EXP 6480464 limonene inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:29251412 lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Mitogens results in increased expression of ACTA2 protein] more ... CTD PMID:21251946 more ... lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of ACTA2 protein CTD PMID:29775649 lipopolysaccharide increases expression ISO RGD:1348351 6480464 Lipopolysaccharides results in increased expression of ACTA2 protein CTD PMID:31935363 lipopolysaccharide multiple interactions ISO RGD:1348351 6480464 2 more ... CTD PMID:31935363 losartan multiple interactions ISO RGD:1616012 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of ACTA2 protein], Losartan inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] CTD PMID:33007385 losartan multiple interactions ISO RGD:1348351 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of ACTA2 protein] CTD PMID:28578904 losartan decreases expression EXP 6480464 Losartan results in decreased expression of ACTA2 mRNA, Losartan results in decreased expression of ACTA2 protein CTD PMID:15100363 , PMID:28091615 lovastatin decreases expression ISO RGD:1348351 6480464 Lovastatin results in decreased expression of ACTA2 protein CTD PMID:22129737 lovastatin multiple interactions ISO RGD:1348351 6480464 Lovastatin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:22129737 lucanthone increases expression ISO RGD:1348351 6480464 Lucanthone results in increased expression of ACTA2 mRNA CTD PMID:21148553 luteolin multiple interactions ISO RGD:1616012 6480464 Luteolin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:19747501 LY 364947 multiple interactions ISO RGD:1616012 6480464 Ly-364947 inhibits the reaction [TGFB3 protein results in increased expression of ACTA2 mRNA] CTD PMID:25566828 LY294002 multiple interactions ISO RGD:1348351 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [nickel monoxide analog results in increased expression of ACTA2 protein] CTD PMID:33895847 malonaldehyde increases expression EXP 6480464 Malondialdehyde results in increased expression of ACTA2 protein CTD PMID:7593635 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of ACTA2 mRNA CTD PMID:28801915 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:26882442 mercaptoethanol multiple interactions ISO RGD:1348351 6480464 [Mercaptoethanol co-treated with Ascorbic Acid] results in increased expression of ACTA2 protein CTD PMID:17053324 mesalamine multiple interactions EXP 6480464 Mesalamine inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:29738702 metacetamol decreases expression ISO RGD:1616012 6480464 3-hydroxyacetanilide results in decreased expression of ACTA2 mRNA CTD PMID:18544908 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Dietary Fats results in increased expression of ACTA2 protein], Metformin promotes the reaction [dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of ACTA2 protein]] CTD PMID:27551045 , PMID:30551545 methotrexate increases expression ISO RGD:1348351 6480464 Methotrexate results in increased expression of ACTA2 mRNA, Methotrexate results in increased expression of ACTA2 protein CTD PMID:27605418 , PMID:31170432 methyl methanesulfonate increases expression ISO RGD:1348351 6480464 Methyl Methanesulfonate results in increased expression of ACTA2 mRNA CTD PMID:23649840 methylglyoxal increases expression ISO RGD:1616012 6480464 Pyruvaldehyde results in increased expression of ACTA2 protein CTD PMID:22101032 methylglyoxal multiple interactions ISO RGD:1616012 6480464 epigallocatechin gallate inhibits the reaction [Pyruvaldehyde results in increased expression of ACTA2 protein] CTD PMID:22101032 methylmercury chloride increases expression ISO RGD:1348351 6480464 methylmercuric chloride results in increased expression of ACTA2 mRNA CTD PMID:26272509 methylmercury chloride multiple interactions ISO RGD:1348351 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTA2 mRNA CTD PMID:27188386 methylseleninic acid increases expression ISO RGD:1348351 6480464 methylselenic acid results in increased expression of ACTA2 mRNA CTD PMID:18548127 mirtazapine multiple interactions ISO RGD:1616012 6480464 mirtazapine inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:28623179 mitogen increases expression EXP 6480464 Mitogens results in increased expression of ACTA2 protein CTD PMID:29760339 mitogen multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Mitogens results in increased expression of ACTA2 protein], Thioctic Acid inhibits the reaction [Mitogens results in increased expression of ACTA2 protein] CTD PMID:29760339 MK-2206 multiple interactions ISO RGD:1348351 6480464 [gamma-mangostin co-treated with MK 2206] results in decreased expression of ACTA2 protein, MK 2206 inhibits the reaction [Radon results in increased expression of ACTA2 protein] CTD PMID:30502394 , PMID:32949624 MK-2206 decreases expression ISO RGD:1348351 6480464 MK 2206 results in decreased expression of ACTA2 protein CTD PMID:30502394 ML-7 decreases expression EXP 6480464 ML 7 results in decreased expression of ACTA2 CTD PMID:11868461 ML-7 affects localization ISO RGD:1348351 6480464 ML 7 affects the localization of ACTA2 protein CTD PMID:11591817 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of ACTA2 protein CTD PMID:31325423 , PMID:31734320 monocrotaline multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Monocrotaline results in increased expression of ACTA2 protein] CTD PMID:31325423 montelukast multiple interactions EXP 6480464 montelukast inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] CTD PMID:21381050 morin multiple interactions EXP 6480464 morin inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 mRNA], morin inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 protein] CTD PMID:18629640 myricitrin multiple interactions ISO RGD:1616012 6480464 myricitrin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:25656916 N-acetyl-1,4-benzoquinone imine increases expression ISO RGD:1348351 6480464 N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 mRNA, N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 protein CTD PMID:28286204 , PMID:29355602 N-acetyl-1,4-benzoquinone imine multiple interactions ISO RGD:1348351 6480464 andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 mRNA], andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 protein] CTD PMID:29355602 N-acetyl-L-cysteine multiple interactions ISO RGD:1616012 6480464 Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of ACTA2 protein], Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ACTA2 protein] CTD PMID:21134390 , PMID:32659284 N-acetyl-L-cysteine multiple interactions ISO RGD:1348351 6480464 Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of ACTA2 protein], Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:16757516 , PMID:33131013 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:1616012 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ACTA2 mRNA CTD PMID:25566086 N-nitrosodiethylamine increases expression ISO RGD:1616012 6480464 Diethylnitrosamine results in increased expression of ACTA2 protein CTD PMID:18522880 , PMID:33290806 N-nitrosodiethylamine multiple interactions ISO RGD:1616012 6480464 salvianolic acid B affects the reaction [SMAD3 protein modified form affects the reaction [Diethylnitrosamine results in increased expression of ACTA2 protein]] more ... CTD PMID:33290806 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ACTA2 protein CTD PMID:19822196 , PMID:26589970 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ACTA2 mRNA, Dimethylnitrosamine results in increased expression of ACTA2 protein CTD PMID:12956909 more ... N-nitrosodimethylamine increases expression ISO RGD:1616012 6480464 Dimethylnitrosamine results in increased expression of ACTA2 mRNA, Dimethylnitrosamine results in increased expression of ACTA2 protein CTD PMID:18239293 , PMID:19647758 N-nitrosodimethylamine multiple interactions ISO RGD:1616012 6480464 Vitamin B 12 inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 mRNA] CTD PMID:18239293 N-nitrosodimethylamine multiple interactions EXP 6480464 [Drugs more ... CTD PMID:12956909 more ... naloxone multiple interactions EXP 6480464 Naloxone inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 protein] CTD PMID:17989109 nickel atom multiple interactions ISO RGD:1348351 6480464 [2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] inhibits the reaction [Nickel results in increased expression of ACTA2 mRNA] CTD PMID:19781536 nickel atom decreases expression ISO RGD:1348351 6480464 Nickel results in decreased expression of ACTA2 mRNA CTD PMID:24768652 , PMID:25583101 nickel atom increases expression ISO RGD:1348351 6480464 Nickel results in increased expression of ACTA2 mRNA CTD PMID:19781536 nickel dichloride increases expression ISO RGD:1616012 6480464 nickel chloride results in increased expression of ACTA2 protein CTD PMID:30055191 nickel dichloride multiple interactions ISO RGD:1348351 6480464 sodium bisulfide inhibits the reaction [nickel chloride results in increased expression of ACTA2 mRNA], sodium bisulfide inhibits the reaction [nickel chloride results in increased expression of ACTA2 protein] CTD PMID:30055191 nickel dichloride multiple interactions ISO RGD:1616012 6480464 CTH gene mutant form promotes the reaction [nickel chloride results in increased expression of ACTA2 protein] CTD PMID:30055191 nickel dichloride increases expression ISO RGD:1348351 6480464 nickel chloride results in increased expression of ACTA2 mRNA, nickel chloride results in increased expression of ACTA2 protein CTD PMID:30055191 nickel subsulfide affects expression EXP 6480464 nickel subsulfide affects the expression of ACTA2 mRNA CTD PMID:24952340 niclosamide multiple interactions ISO RGD:1348351 6480464 Niclosamide inhibits the reaction [[Lapatinib results in decreased susceptibility to Lapatinib] which results in increased expression of ACTA2 protein] CTD PMID:26643609 niclosamide multiple interactions ISO RGD:1616012 6480464 Niclosamide inhibits the reaction [Doxorubicin results in increased expression of ACTA2 protein] CTD PMID:28318631 nicotine multiple interactions ISO RGD:1616012 6480464 Nicotine promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA], Nicotine promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:33640489 nitrofen increases expression ISO RGD:1616012 6480464 nitrofen results in increased expression of ACTA2 mRNA CTD PMID:9575882 nocodazole increases expression ISO RGD:1348351 6480464 Nocodazole results in increased expression of ACTA2 mRNA CTD PMID:31170432 nocodazole multiple interactions ISO RGD:1348351 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Nocodazole results in increased expression of ACTA2 mRNA] CTD PMID:31170432 NS-398 multiple interactions ISO RGD:1348351 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ACTA2 protein] CTD PMID:27697457 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ACTA2 protein CTD PMID:16622519 ochratoxin A increases expression ISO RGD:1616012 6480464 ochratoxin A results in increased expression of ACTA2 mRNA, ochratoxin A results in increased expression of ACTA2 protein CTD PMID:32617660 , PMID:33543323 ochratoxin A multiple interactions ISO RGD:1348351 6480464 [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 mRNA, [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 protein CTD PMID:29673704 ochratoxin A increases expression ISO RGD:1348351 6480464 ochratoxin A results in increased expression of ACTA2 mRNA, ochratoxin A results in increased expression of ACTA2 protein CTD PMID:29673704 , PMID:32617660 ochratoxin A multiple interactions EXP 6480464 Ethanol affects the reaction [ochratoxin A results in increased expression of ACTA2 protein] CTD PMID:16622519 octreotide multiple interactions EXP 6480464 Octreotide inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:12890342 olaparib multiple interactions ISO RGD:1616012 6480464 olaparib inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 mRNA] CTD PMID:27984176 oleanolic acid multiple interactions EXP 6480464 Oleanolic Acid analog inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] CTD PMID:17922224 oleanolic acid multiple interactions ISO RGD:1616012 6480464 Oleanolic Acid analog inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] CTD PMID:17922224 oleic acid increases expression ISO RGD:1348351 6480464 Oleic Acid results in increased expression of ACTA2 mRNA CTD PMID:32918399 oleic acid multiple interactions ISO RGD:1348351 6480464 [Oleic Acid co-treated with Palmitic Acid] results in increased expression of ACTA2 mRNA CTD PMID:26187275 olmesartan multiple interactions EXP 6480464 olmesartan inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein], olmesartan inhibits the reaction [Fish Oils inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]] CTD PMID:24144775 ouabain affects expression ISO RGD:1348351 6480464 Ouabain affects the expression of ACTA2 protein CTD PMID:17268060 Pachymic acid multiple interactions ISO RGD:1348351 6480464 pachymic acid analog inhibits the reaction [AGT protein results in increased expression of ACTA2 protein] CTD PMID:28578904 paclitaxel increases expression ISO RGD:1348351 6480464 Paclitaxel results in increased expression of ACTA2 protein CTD PMID:31170432 panobinostat decreases expression ISO RGD:1348351 6480464 Panobinostat results in decreased expression of ACTA2 mRNA CTD PMID:30481203 paracetamol increases expression ISO RGD:1348351 6480464 Acetaminophen results in increased expression of ACTA2 mRNA CTD PMID:22230336 paracetamol multiple interactions ISO RGD:1616012 6480464 andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 mRNA] more ... CTD PMID:28286204 more ... paracetamol affects expression ISO RGD:1616012 6480464 Acetaminophen affects the expression of ACTA2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1616012 6480464 Acetaminophen results in increased expression of ACTA2 mRNA, Acetaminophen results in increased expression of ACTA2 protein CTD PMID:18544908 more ... paraquat multiple interactions ISO RGD:1348351 6480464 CMA1 protein promotes the reaction [Paraquat results in increased expression of ACTA2 protein], HIF1A protein affects the reaction [Paraquat results in increased expression of ACTA2 protein] CTD PMID:19969051 , PMID:26781174 paraquat multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in increased expression of ACTA2 mRNA]] more ... CTD PMID:26781174 more ... paraquat increases expression EXP 6480464 Paraquat results in increased expression of ACTA2 mRNA, Paraquat results in increased expression of ACTA2 protein CTD PMID:25873302 more ... paraquat increases expression ISO RGD:1348351 6480464 Paraquat results in increased expression of ACTA2 protein CTD PMID:26781174 paraquat increases expression ISO RGD:1616012 6480464 Paraquat results in increased expression of ACTA2 mRNA, Paraquat results in increased expression of ACTA2 protein CTD PMID:17215068 more ... paraquat multiple interactions ISO RGD:1616012 6480464 ADIPOQ protein inhibits the reaction [Paraquat results in increased expression of ACTA2 mRNA] more ... CTD PMID:24893116 more ... Pentoxifylline decreases expression EXP 6480464 Pentoxifylline results in decreased expression of ACTA2 protein CTD PMID:14996430 Pentoxifylline multiple interactions ISO RGD:1348351 6480464 Pentoxifylline promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] CTD PMID:18207697 perindopril decreases expression EXP 6480464 Perindopril results in decreased expression of ACTA2 protein CTD PMID:12076858 perindopril multiple interactions EXP 6480464 [Imatinib Mesylate co-treated with Perindopril] inhibits the reaction [Carbon Tetrachloride affects the expression of ACTA2 mRNA], Perindopril inhibits the reaction [Carbon Tetrachloride affects the expression of ACTA2 mRNA] CTD PMID:16596278 phenethyl isothiocyanate affects binding ISO RGD:1348351 6480464 ACTA2 protein binds to phenethyl isothiocyanate CTD PMID:21838287 phenethyl isothiocyanate increases expression ISO RGD:1348351 6480464 phenethyl isothiocyanate results in increased expression of ACTA2 mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:1348351 6480464 Phenobarbital affects the expression of ACTA2 mRNA CTD PMID:19159669 phenylephrine multiple interactions EXP 6480464 MYOCD protein affects the reaction [Phenylephrine results in increased expression of ACTA2 mRNA] CTD PMID:16556869 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of ACTA2 mRNA CTD PMID:16556869 , PMID:18158353 phenylmercury acetate increases expression ISO RGD:1348351 6480464 Phenylmercuric Acetate results in increased expression of ACTA2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1348351 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTA2 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of ACTA2 mRNA CTD PMID:15215175 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of ACTA2 mRNA CTD PMID:15059925 pioglitazone multiple interactions EXP 6480464 pioglitazone affects the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:16484506 pioglitazone multiple interactions ISO RGD:1348351 6480464 Pioglitazone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] CTD PMID:32613381 pioglitazone multiple interactions ISO RGD:1616012 6480464 pioglitazone inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACTA2 mRNA], pioglitazone inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:15052691 , PMID:18513333 pirfenidone decreases expression ISO RGD:1348351 6480464 pirfenidone results in decreased expression of ACTA2 mRNA, pirfenidone results in decreased expression of ACTA2 protein CTD PMID:24706986 pirfenidone decreases expression EXP 6480464 pirfenidone results in decreased expression of ACTA2 protein CTD PMID:28091615 pirfenidone multiple interactions ISO RGD:1616012 6480464 pirfenidone inhibits the reaction [Paraquat results in increased expression of ACTA2 mRNA] CTD PMID:29273418 pirinixic acid decreases expression ISO RGD:1616012 6480464 pirinixic acid results in decreased expression of ACTA2 mRNA CTD PMID:20059764 pirinixic acid increases expression ISO RGD:1616012 6480464 pirinixic acid results in increased expression of ACTA2 mRNA CTD PMID:20813756 , PMID:23811191 pirinixic acid multiple interactions ISO RGD:1616012 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of ACTA2 mRNA] CTD PMID:20059764 poly(guanylic acid) multiple interactions EXP 6480464 Poly G inhibits the reaction [Particulate Matter results in increased expression of ACTA2 mRNA] more ... CTD PMID:30391304 , PMID:31028789 potassium dichromate multiple interactions ISO RGD:1616012 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ACTA2 protein, SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ACTA2 protein] CTD PMID:31756458 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1616012 6480464 Pregnenolone Carbonitrile results in increased expression of ACTA2 mRNA CTD PMID:28903501 proanthocyanidin multiple interactions EXP 6480464 Proanthocyanidins inhibits the reaction [Doxorubicin results in increased expression of ACTA2 protein] CTD PMID:33484087 probucol multiple interactions ISO RGD:1348351 6480464 Probucol inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:22129737 progesterone increases expression ISO RGD:1348351 6480464 Progesterone results in increased expression of ACTA2 mRNA CTD PMID:20864642 , PMID:21540246 progesterone multiple interactions EXP 6480464 Progesterone promotes the reaction [Hydrogen Peroxide results in increased expression of ACTA2 protein] CTD PMID:16284289 progesterone decreases expression ISO RGD:1348351 6480464 Progesterone results in decreased expression of ACTA2 mRNA CTD PMID:18037150 propanal increases expression ISO RGD:1348351 6480464 propionaldehyde results in increased expression of ACTA2 mRNA CTD PMID:26079696 prostaglandin E2 increases expression ISO RGD:1348351 6480464 Dinoprostone results in increased expression of ACTA2 protein CTD PMID:27697457 puerarin multiple interactions ISO RGD:1616012 6480464 puerarin inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACTA2 mRNA], puerarin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:27318789 , PMID:31273855 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:15078482 quartz increases expression ISO RGD:1348351 6480464 Quartz results in increased expression of ACTA2 mRNA CTD PMID:27381660 quartz multiple interactions ISO RGD:1348351 6480464 Ascorbic Acid promotes the reaction [Quartz results in increased expression of ACTA2 mRNA] CTD PMID:27381660 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of ACTA2 mRNA, Quercetin results in decreased expression of ACTA2 protein CTD PMID:27601294 , PMID:9581680 quercetin increases expression EXP 6480464 Quercetin results in increased expression of ACTA2 mRNA CTD PMID:23117658 quercetin multiple interactions EXP 6480464 [Warfarin co-treated with Vitamin K co-treated with Quercetin] results in increased expression of ACTA2 mRNA more ... CTD PMID:12956909 more ... quercetin decreases expression ISO RGD:1348351 6480464 Quercetin results in decreased expression of ACTA2 mRNA, Quercetin results in decreased expression of ACTA2 protein CTD PMID:33070227 quercetin increases expression ISO RGD:1348351 6480464 Quercetin results in increased expression of ACTA2 mRNA CTD PMID:21632981 quercetin multiple interactions ISO RGD:1348351 6480464 Quercetin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein], SHH protein inhibits the reaction [Quercetin results in decreased expression of ACTA2 protein] CTD PMID:22871832 , PMID:33070227 quercetin multiple interactions ISO RGD:1616012 6480464 Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 protein] more ... CTD PMID:22915297 , PMID:27601294 radon atom increases expression ISO RGD:1348351 6480464 Radon results in increased expression of ACTA2 mRNA, Radon results in increased expression of ACTA2 protein CTD PMID:32949624 radon atom multiple interactions ISO RGD:1348351 6480464 MK 2206 inhibits the reaction [Radon results in increased expression of ACTA2 protein], ridaforolimus inhibits the reaction [Radon results in increased expression of ACTA2 protein] CTD PMID:32949624 radon atom increases expression ISO RGD:1616012 6480464 Radon results in increased expression of ACTA2 protein CTD PMID:32949624 radon(0) increases expression ISO RGD:1348351 6480464 Radon results in increased expression of ACTA2 mRNA, Radon results in increased expression of ACTA2 protein CTD PMID:32949624 radon(0) multiple interactions ISO RGD:1348351 6480464 MK 2206 inhibits the reaction [Radon results in increased expression of ACTA2 protein], ridaforolimus inhibits the reaction [Radon results in increased expression of ACTA2 protein] CTD PMID:32949624 radon(0) increases expression ISO RGD:1616012 6480464 Radon results in increased expression of ACTA2 protein CTD PMID:32949624 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Carbon Tetrachloride affects the expression of ACTA2 mRNA] more ... CTD PMID:23262250 , PMID:25064540 resveratrol increases expression ISO RGD:1348351 6480464 Resveratrol results in increased expression of ACTA2 mRNA CTD PMID:30481203 resveratrol decreases expression ISO RGD:1616012 6480464 resveratrol results in decreased expression of ACTA2 mRNA, resveratrol results in decreased expression of ACTA2 protein CTD PMID:27345520 resveratrol decreases expression ISO RGD:1348351 6480464 resveratrol results in decreased expression of ACTA2 mRNA, resveratrol results in decreased expression of ACTA2 protein CTD PMID:23815229 more ... resveratrol multiple interactions ISO RGD:1348351 6480464 3-deazaneplanocin inhibits the reaction [resveratrol results in decreased expression of ACTA2 mRNA] more ... CTD PMID:25707573 , PMID:26934322 resveratrol multiple interactions ISO RGD:1616012 6480464 resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of ACTA2 mRNA] more ... CTD PMID:23297412 , PMID:25234611 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of ACTA2 mRNA, resveratrol results in decreased expression of ACTA2 protein CTD PMID:20797428 more ... Rhein multiple interactions EXP 6480464 rhein inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:12546737 ridaforolimus multiple interactions ISO RGD:1348351 6480464 ridaforolimus inhibits the reaction [Radon results in increased expression of ACTA2 protein] CTD PMID:32949624 rifaximin multiple interactions ISO RGD:1348351 6480464 [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of ACTA2 mRNA CTD PMID:22790967 rimonabant decreases expression EXP 6480464 Rimonabant results in decreased expression of ACTA2 mRNA CTD PMID:21863215 rivaroxaban multiple interactions EXP 6480464 Rivaroxaban inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:30719803 Ro 31-8220 multiple interactions ISO RGD:1348351 6480464 Ro 31-8220 inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:16757516 rosmarinic acid decreases expression EXP 6480464 rosmarinic acid results in decreased expression of ACTA2 protein CTD PMID:28789951 rosmarinic acid multiple interactions EXP 6480464 rosmarinic acid inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:28789951 rotenone multiple interactions ISO RGD:1348351 6480464 Rotenone inhibits the reaction [Aldosterone results in increased expression of ACTA2 mRNA], Rotenone inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein] CTD PMID:17596522 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ACTA2 mRNA CTD PMID:28374803 rotenone multiple interactions ISO RGD:1616012 6480464 Rotenone inhibits the reaction [Desoxycorticosterone results in increased expression of ACTA2 protein] CTD PMID:17596522 Salvianolic acid A multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [PDGFB protein results in increased expression of ACTA2 protein], salvianolic acid A inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:19822164 salvianolic acid B multiple interactions EXP 6480464 salvianolic acid B inhibits the reaction [PDGFB protein results in increased expression of ACTA2 protein], salvianolic acid B inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:19822164 salvianolic acid B multiple interactions ISO RGD:1616012 6480464 salvianolic acid B affects the reaction [SMAD3 protein modified form affects the reaction [Diethylnitrosamine results in increased expression of ACTA2 protein]], salvianolic acid B inhibits the reaction [Diethylnitrosamine results in increased expression of ACTA2 protein] CTD PMID:33290806 saroglitazar multiple interactions ISO RGD:1348351 6480464 saroglitazar inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] CTD PMID:32613381 SB 203580 multiple interactions ISO RGD:1348351 6480464 SB 203580 inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:11591817 more ... SB 203580 decreases expression ISO RGD:1348351 6480464 SB 203580 results in decreased expression of ACTA2 mRNA CTD PMID:29673704 SB 431542 multiple interactions ISO RGD:1348351 6480464 4-(5-benzo(1 more ... CTD PMID:27188386 more ... SB 431542 decreases expression ISO RGD:1616012 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased expression of ACTA2 protein CTD PMID:31285260 SB 431542 multiple interactions EXP 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [TAC1 protein modified form results in increased expression of ACTA2 protein] CTD PMID:28647476 SB 431542 multiple interactions ISO RGD:1616012 6480464 4-(5-benzo(1 more ... CTD PMID:31285260 , PMID:31706003 SCH772984 multiple interactions ISO RGD:1616012 6480464 SCH772984 inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:31706003 serpentine asbestos multiple interactions ISO RGD:1348351 6480464 TGFB1 protein affects the reaction [Asbestos, Serpentine results in increased expression of ACTA2 protein] CTD PMID:26685284 serpentine asbestos decreases expression ISO RGD:1348351 6480464 Asbestos, Serpentine results in decreased expression of ACTA2 mRNA CTD PMID:29523930 serpentine asbestos increases expression ISO RGD:1348351 6480464 Asbestos more ... CTD PMID:24160326 more ... Shikonin decreases expression ISO RGD:1348351 6480464 shikonin results in decreased expression of ACTA2 mRNA CTD PMID:25591861 sildenafil citrate decreases expression EXP 6480464 Sildenafil Citrate results in decreased expression of ACTA2 protein CTD PMID:14996430 silicon dioxide decreases expression ISO RGD:1348351 6480464 Silicon Dioxide analog results in decreased expression of ACTA2 mRNA CTD PMID:25895662 silicon dioxide multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] more ... CTD PMID:30391304 more ... silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of ACTA2 mRNA, Silicon Dioxide results in increased expression of ACTA2 protein CTD PMID:30391304 more ... silicon dioxide increases expression ISO RGD:1616012 6480464 Silicon Dioxide results in increased expression of ACTA2 mRNA, Silicon Dioxide results in increased expression of ACTA2 protein CTD PMID:29113749 more ... silicon dioxide multiple interactions ISO RGD:1348351 6480464 [Silicon Dioxide results in increased secretion of TGFB1 protein] which results in increased expression of ACTA2 protein more ... CTD PMID:29113749 more ... silicon dioxide increases expression ISO RGD:1348351 6480464 Silicon Dioxide results in increased expression of ACTA2 protein CTD PMID:29113749 , PMID:32097614 silicon dioxide multiple interactions ISO RGD:1616012 6480464 2-(1-carboxy-2-(3-(3 more ... CTD PMID:27616297 more ... silver atom decreases expression ISO RGD:1616012 6480464 Silver results in decreased expression of ACTA2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1616012 6480464 Silver results in decreased expression of ACTA2 mRNA CTD PMID:27131904 simvastatin multiple interactions ISO RGD:1348351 6480464 Simvastatin inhibits the reaction [TGFB1 results in increased expression of ACTA2 mRNA] CTD PMID:15677772 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of ACTA2 protein CTD PMID:15855201 sirolimus multiple interactions ISO RGD:1348351 6480464 [Sirolimus co-treated with IGF1 protein] results in increased expression of ACTA2 protein CTD PMID:17908691 sodium arsenate increases expression ISO RGD:1616012 6480464 sodium arsenate results in increased expression of ACTA2 mRNA CTD PMID:21795629 sodium arsenite increases methylation ISO RGD:1348351 6480464 sodium arsenite results in increased methylation of ACTA2 gene CTD PMID:25199682 sodium arsenite affects expression ISO RGD:1348351 6480464 sodium arsenite affects the expression of ACTA2 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:1348351 6480464 sodium arsenite results in increased expression of ACTA2 mRNA, sodium arsenite results in increased expression of ACTA2 protein CTD PMID:29277653 , PMID:30191986 sodium arsenite multiple interactions ISO RGD:1348351 6480464 MIR191 mRNA promotes the reaction [sodium arsenite results in increased expression of ACTA2 protein], sodium arsenite results in increased expression of and affects the localization of ACTA2 protein CTD PMID:29277653 , PMID:30191986 sodium arsenite increases expression ISO RGD:1616012 6480464 sodium arsenite results in increased expression of ACTA2 mRNA, sodium arsenite results in increased expression of ACTA2 protein CTD PMID:19095001 , PMID:21134390 sodium arsenite decreases expression ISO RGD:1616012 6480464 sodium arsenite results in decreased expression of ACTA2 mRNA, sodium arsenite results in decreased expression of ACTA2 protein CTD PMID:18812580 , PMID:26438402 sodium arsenite multiple interactions ISO RGD:1616012 6480464 [APOE protein affects the susceptibility to sodium arsenite] which results in decreased expression of ACTA2 protein more ... CTD PMID:21134390 more ... sodium arsenite decreases expression ISO RGD:1348351 6480464 sodium arsenite results in decreased expression of ACTA2 mRNA CTD PMID:19615344 sodium dichromate decreases expression ISO RGD:1616012 6480464 sodium bichromate results in decreased expression of ACTA2 mRNA CTD PMID:31558096 sodium fluoride decreases expression ISO RGD:1616012 6480464 Sodium Fluoride results in decreased expression of ACTA2 protein CTD PMID:27548804 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of ACTA2 mRNA CTD PMID:29758312 sodium fluoride multiple interactions EXP 6480464 protocatechuic acid methyl ester inhibits the reaction [Sodium Fluoride results in increased expression of ACTA2 mRNA] CTD PMID:29758312 sorafenib decreases expression EXP 6480464 sorafenib results in decreased expression of ACTA2 mRNA CTD PMID:24321339 sorbinil multiple interactions ISO RGD:1348351 6480464 sorbinil inhibits the reaction [AKR1B1 protein results in increased expression of ACTA2 mRNA] CTD PMID:28137510 spironolactone multiple interactions EXP 6480464 Spironolactone inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein] CTD PMID:25204689 SR 144528 multiple interactions ISO RGD:1616012 6480464 SR 144528 inhibits the reaction [celastrol inhibits the reaction [Folic Acid results in increased expression of ACTA2 protein]] CTD PMID:29789558 streptozocin multiple interactions ISO RGD:1616012 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of ACTA2 mRNA more ... CTD PMID:29420703 , PMID:29988851 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Fructose] results in increased expression of ACTA2 protein more ... CTD PMID:30551545 sulfasalazine multiple interactions EXP 6480464 Sulfasalazine inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:15633128 sulforaphane affects binding ISO RGD:1348351 6480464 ACTA2 protein binds to sulforaphane CTD PMID:21838287 sulforaphane multiple interactions ISO RGD:1616012 6480464 sulforaphane inhibits the reaction [fenamidone results in increased expression of ACTA2 mRNA] CTD PMID:27029645 sunitinib decreases expression EXP 6480464 sunitinib results in decreased expression of ACTA2 mRNA CTD PMID:24321339 sunitinib decreases expression ISO RGD:1348351 6480464 Sunitinib results in decreased expression of ACTA2 mRNA CTD PMID:31533062 Swertiamarin multiple interactions EXP 6480464 swertiamarin inhibits the reaction [Testosterone results in increased expression of ACTA2 mRNA] CTD PMID:27866977 tacrolimus hydrate increases expression ISO RGD:1616012 6480464 Tacrolimus results in increased expression of ACTA2 protein CTD PMID:29362864 tamoxifen affects expression ISO RGD:1616012 6480464 Tamoxifen affects the expression of ACTA2 mRNA CTD PMID:17555576 Tanshinone I multiple interactions EXP 6480464 tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] CTD PMID:32097614 Tanshinone I multiple interactions ISO RGD:1348351 6480464 NFE2L2 protein promotes the reaction [tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]], tanshinone inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein] CTD PMID:32097614 taurine multiple interactions ISO RGD:1616012 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] CTD PMID:30677399 taurine multiple interactions ISO RGD:1348351 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] CTD PMID:30677399 testosterone multiple interactions ISO RGD:1348351 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ACTA2 mRNA CTD PMID:21592394 testosterone increases expression EXP 6480464 Testosterone results in increased expression of ACTA2 mRNA CTD PMID:27866977 testosterone multiple interactions EXP 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of ACTA2 mRNA] more ... CTD PMID:27866977 testosterone increases expression ISO RGD:1348351 6480464 Testosterone results in increased expression of ACTA2 mRNA CTD PMID:21592394 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of ACTA2 mRNA, Carbon Tetrachloride affects the expression of ACTA2 protein CTD PMID:23262250 tetrachloromethane increases expression ISO RGD:1616012 6480464 Carbon Tetrachloride results in increased expression of ACTA2 more ... CTD PMID:11481614 more ... tetrachloromethane multiple interactions EXP 6480464 [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid co-treated with Carbon Tetrachloride] results in increased expression of ACTA2 protein more ... CTD PMID:11408273 more ... tetrachloromethane multiple interactions ISO RGD:1616012 6480464 (+)-JQ1 compound inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] more ... CTD PMID:11481614 more ... tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ACTA2 mRNA, Carbon Tetrachloride results in increased expression of ACTA2 protein CTD PMID:11408273 more ... tetrachloromethane decreases expression ISO RGD:1348351 6480464 Carbon Tetrachloride results in decreased expression of ACTA2 mRNA CTD PMID:18207697 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ACTA2 protein CTD PMID:17069927 tetrachloromethane decreases expression ISO RGD:1616012 6480464 Carbon Tetrachloride results in decreased expression of ACTA2 mRNA CTD PMID:17640975 tetrachloromethane multiple interactions ISO RGD:1348351 6480464 Pentoxifylline promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] CTD PMID:18207697 tetramethylpyrazine multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Hydrogen Peroxide results in increased expression of ACTA2 mRNA] CTD PMID:23022513 tetramethylpyrazine decreases expression ISO RGD:1348351 6480464 tetramethylpyrazine results in decreased expression of ACTA2 mRNA, tetramethylpyrazine results in decreased expression of ACTA2 protein CTD PMID:27477297 tetramethylpyrazine multiple interactions ISO RGD:1616012 6480464 NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of ACTA2 protein]] more ... CTD PMID:27477297 more ... tetramethylpyrazine multiple interactions ISO RGD:1348351 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of ACTA2 mRNA], NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of ACTA2 protein] CTD PMID:27477297 thalidomide multiple interactions EXP 6480464 [Thalidomide co-treated with Dimethylnitrosamine] results in decreased expression of ACTA2 protein more ... CTD PMID:16604421 more ... thalidomide decreases expression EXP 6480464 Thalidomide results in decreased expression of ACTA2 protein CTD PMID:17174718 thapsigargin increases expression ISO RGD:1348351 6480464 Thapsigargin results in increased expression of ACTA2 mRNA CTD PMID:22378314 thapsigargin decreases expression ISO RGD:1348351 6480464 Thapsigargin results in decreased expression of ACTA2 mRNA CTD PMID:29453283 theophylline multiple interactions ISO RGD:1348351 6480464 Theophylline inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:16430859 thioacetamide multiple interactions ISO RGD:1616012 6480464 2 more ... CTD PMID:12085344 more ... thioacetamide increases expression ISO RGD:1348351 6480464 Thioacetamide results in increased expression of ACTA2 protein CTD PMID:27605418 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ACTA2 more ... CTD PMID:11172339 more ... thioacetamide increases expression ISO RGD:1616012 6480464 Thioacetamide results in increased expression of ACTA2 mRNA, Thioacetamide results in increased expression of ACTA2 protein CTD PMID:12085344 more ... thioacetamide multiple interactions EXP 6480464 1 more ... CTD PMID:11172339 more ... thymidine increases expression ISO RGD:1348351 6480464 Thymidine results in increased expression of ACTA2 mRNA CTD PMID:31170432 thymidine multiple interactions ISO RGD:1348351 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Thymidine results in increased expression of ACTA2 mRNA] CTD PMID:31170432 thymoquinone multiple interactions ISO RGD:1616012 6480464 thymoquinone inhibits the reaction [Ethanol results in increased expression of ACTA2 protein] more ... CTD PMID:27375216 more ... thymoquinone multiple interactions ISO RGD:1348351 6480464 thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of ACTA2 protein], thymoquinone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:27688165 , PMID:31935363 Tiron multiple interactions ISO RGD:1616012 6480464 1 more ... CTD PMID:23517783 titanium dioxide affects expression ISO RGD:1616012 6480464 titanium dioxide affects the expression of ACTA2 mRNA CTD PMID:23557971 titanium dioxide increases expression ISO RGD:1616012 6480464 titanium dioxide results in increased expression of ACTA2 mRNA CTD PMID:27760801 tolcapone affects binding EXP 6480464 tolcapone binds to ACTA2 protein CTD PMID:19783845 TRAM-34 multiple interactions EXP 6480464 TRAM 34 inhibits the reaction [Paraquat results in increased expression of ACTA2 protein] CTD PMID:30036685 triadimefon decreases expression ISO RGD:1348351 6480464 triadimefon results in decreased expression of ACTA2 mRNA CTD PMID:26705709 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of ACTA2 protein CTD PMID:27521499 trichostatin A increases expression ISO RGD:1348351 6480464 trichostatin A results in increased expression of ACTA2 mRNA CTD PMID:26272509 trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of ACTA2 protein CTD PMID:12445420 trichostatin A multiple interactions ISO RGD:1616012 6480464 trichostatin A inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CTD PMID:27396813 trichostatin A multiple interactions ISO RGD:1348351 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTA2 mRNA CTD PMID:27188386 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of ACTA2 CTD PMID:15211114 troglitazone multiple interactions ISO RGD:1348351 6480464 troglitazone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] CTD PMID:18162602 tunicamycin increases expression ISO RGD:1348351 6480464 Tunicamycin results in increased expression of ACTA2 mRNA CTD PMID:22378314 urethane decreases expression ISO RGD:1348351 6480464 Urethane results in decreased expression of ACTA2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1616012 6480464 Valproic Acid affects the expression of ACTA2 mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:1348351 6480464 Valproic Acid results in increased expression of ACTA2 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:1616012 6480464 Valproic Acid results in increased expression of ACTA2 mRNA CTD PMID:24896083 valproic acid affects expression ISO RGD:1348351 6480464 Valproic Acid affects the expression of ACTA2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1348351 6480464 Valproic Acid results in decreased expression of ACTA2 mRNA CTD PMID:23527032 , PMID:29154799 vancomycin decreases expression ISO RGD:1616012 6480464 Vancomycin results in decreased expression of ACTA2 mRNA CTD PMID:18930951 verapamil multiple interactions EXP 6480464 Verapamil inhibits the reaction [[Carbon Tetrachloride co-treated with lard co-treated with Ethanol] results in increased expression of ACTA2 protein] CTD PMID:17223571 vildagliptin multiple interactions ISO RGD:1616012 6480464 Vildagliptin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:32956689 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ACTA2 mRNA CTD PMID:19015723 vitamin D multiple interactions ISO RGD:1616012 6480464 Vitamin D inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA], Vitamin D inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] CTD PMID:33309619 vitamin E decreases expression ISO RGD:1348351 6480464 Vitamin E results in decreased expression of ACTA2 mRNA CTD PMID:19244175 vitamin K multiple interactions EXP 6480464 [Warfarin co-treated with Vitamin K co-treated with Quercetin] results in increased expression of ACTA2 mRNA CTD PMID:23117658 vorinostat increases expression ISO RGD:1348351 6480464 vorinostat results in increased expression of ACTA2 protein CTD PMID:20543569 warfarin multiple interactions EXP 6480464 [Warfarin co-treated with Vitamin K co-treated with Quercetin] results in increased expression of ACTA2 mRNA CTD PMID:23117658 WIN 55212-2 decreases expression ISO RGD:1348351 6480464 (3R)-((2 more ... CTD PMID:31991773 WIN 55212-2 multiple interactions ISO RGD:1616012 6480464 (3R)-((2 more ... CTD PMID:31901889 WIN 55212-2 multiple interactions ISO RGD:1348351 6480464 (3R)-((2 more ... CTD PMID:31991773 XL147 multiple interactions ISO RGD:1616012 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ACTA2 mRNA] CTD PMID:29891994 Y-27632 multiple interactions ISO RGD:1348351 6480464 Y 27632 inhibits the reaction [Oxygen results in increased expression of ACTA2 mRNA], Y 27632 inhibits the reaction [Oxygen results in increased expression of ACTA2 protein] CTD PMID:23517783 Y-27632 decreases expression EXP 6480464 Y 27632 results in decreased expression of ACTA2 mRNA CTD PMID:11035001 Y-27632 multiple interactions EXP 6480464 Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of ACTA2 mRNA] more ... CTD PMID:13678700 , PMID:32860865 Y-27632 multiple interactions ISO RGD:1616012 6480464 Y 27632 inhibits the reaction [Oxygen results in increased expression of ACTA2 protein] more ... CTD PMID:23517783 , PMID:33792148 zileuton multiple interactions ISO RGD:1348351 6480464 zileuton inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ACTA2 protein] CTD PMID:27697457 zinc atom decreases expression ISO RGD:1616012 6480464 Zinc deficiency results in decreased expression of ACTA2 protein CTD PMID:25088245 zinc(0) decreases expression ISO RGD:1616012 6480464 Zinc deficiency results in decreased expression of ACTA2 protein CTD PMID:25088245 zoledronic acid increases expression ISO RGD:1616012 6480464 zoledronic acid results in increased expression of ACTA2 protein CTD PMID:28871336 zoledronic acid increases expression ISO RGD:1348351 6480464 zoledronic acid results in increased expression of ACTA2 protein CTD PMID:28871336 zoledronic acid multiple interactions ISO RGD:1616012 6480464 Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein], SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein] CTD PMID:28871336 zoledronic acid multiple interactions ISO RGD:1348351 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein] CTD PMID:28871336
